SLS-009

N/A

Report date: 2023/10/31 09:50:01

Base Information

Drug NameSLS-009
Drug Alias NameSLS-009
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProteolysis
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeelos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeelos Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A